View by Specialty

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 07, 2024
2 min read
Save

Tiny plastics in carotid plaque tied to elevated risk for heart attack, stroke, death

Tiny plastics in carotid plaque tied to elevated risk for heart attack, stroke, death

Among patients with asymptomatic carotid artery disease who had carotid endarterectomy, those whose atheromas contained microplastics and/or nanoplastics had worse outcomes than those whose atheromas did not, researchers reported.

SPONSORED CONTENT
March 07, 2024
2 min read
Save

Better sleep linked to improved verbal memory in multiple sclerosis

Better sleep linked to improved verbal memory in multiple sclerosis

WEST PALM BEACH, Fla. — In two separate cohorts of individuals with multiple sclerosis and memory issues, better sleep was linked to improved verbal memory, according to a poster at ACTRIMS 2024.

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

SPONSORED CONTENT
March 06, 2024
2 min read
Save

Treatment with antibody oligonucleotide conjugate led to improved outcomes in DM1

Treatment with antibody oligonucleotide conjugate led to improved outcomes in DM1

Long-term treatment with IV administration of a novel therapeutic for those with myotonic dystrophy type 1 led to significant improvement in muscle strength and control and improved quality of life, data show.

SPONSORED CONTENT
March 06, 2024
1 min read
Save

Viltolarsen linked to increased pulmonary function in Duchenne muscular dystrophy

Viltolarsen linked to increased pulmonary function in Duchenne muscular dystrophy

Treatment with viltolarsen at 48 weeks improved pulmonary function in a cohort of pediatric patients with Duchenne muscular dystrophy amenable to exon 53 skipping compared with those receiving standard care.

SPONSORED CONTENT
March 05, 2024
1 min read
Save

FDA grants breakthrough device designation to blood-based Alzheimer’s diagnostic assay

FDA grants breakthrough device designation to blood-based Alzheimer’s diagnostic assay

The FDA has granted breakthrough device designation to a phospho-tau 217 blood-based biomarker to assist in the diagnosis of Alzheimer’s disease, according to the manufacturer.

SPONSORED CONTENT
March 05, 2024
2 min read
Save

Givinostat improves range of motion, reduces decline of muscle function in DMD

Givinostat improves range of motion, reduces decline of muscle function in DMD

Treatment with givinostat for ambulatory boys with Duchenne muscular dystrophy led to improved motion and reduced decline of muscle function and strength at 18 months, according to a poster at the 2024 MDA Clinical & Scientific Conference.

SPONSORED CONTENT
March 04, 2024
1 min read
Save

Zolgensma improves motor function at 52 weeks in spinal muscular atrophy

Zolgensma improves motor function at 52 weeks in spinal muscular atrophy

Treatment with Zolgensma improved motor function in a cohort of children with spinal muscular atrophy, according to a poster at the 2024 MDA Clinical & Scientific Conference.

SPONSORED CONTENT
March 04, 2024
1 min read
Save

Pamrevlumab nonsuperior to placebo for boys with Duchenne muscular dystrophy

Pamrevlumab nonsuperior to placebo for boys with Duchenne muscular dystrophy

For young ambulatory boys with Duchenne muscular dystrophy, treatment with pamrevlumab was nonsuperior to placebo after 52 weeks, according to a poster presentation at the 2024 MDA Clinical & Scientific Conference.

SPONSORED CONTENT
March 01, 2024
2 min read
Save

Addressing barriers to technology, telehealth care in underserved populations urgent

Addressing barriers to technology, telehealth care in underserved populations urgent

WEST PALM BEACH, Fla. — For patients with multiple sclerosis living in underserved areas, increasing access to health care professionals and removing barriers of access to technology are urgent needs, according to a speaker at ACTRIMS 2024.

SPONSORED CONTENT
March 01, 2024
1 min read
Save

FDA approves Acthar Gel SelfJect injector in autoimmune, inflammatory conditions

FDA approves Acthar Gel SelfJect injector in autoimmune, inflammatory conditions

The FDA has approved a supplemental new drug application for an Acthar Gel injector for the treatment of several chronic and acute inflammatory and autoimmune conditions, according to the manufacturer.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails